Pacific Palisades, CA, United States of America

Frederick C Beddingfield

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Frederick C. Beddingfield

Introduction

Frederick C. Beddingfield, a distinguished inventor based in Pacific Palisades, California, has made significant contributions to the field of healthcare innovation. With a focus on treatments for conditions arising from chemotherapy, his work aims to enhance patients' quality of life during challenging times.

Latest Patents

Beddingfield holds three patents, the most notable being a topical treatment for chemotherapy-induced eyelash loss, also known as hypotrichosis. This invention utilizes prostamide F2 alpha agonists, specifically bimatoprost, to create compositions and methods that assist in the treatment of this condition. These compositions can be applied before, during, and after chemotherapy, offering a proactive approach to managing eyelash loss for patients undergoing such treatments.

Career Highlights

Frederick C. Beddingfield's innovative contributions primarily come through his work at Allergan, Inc., a leading company in pharmaceutical advancements. His role has allowed him to focus on research and development geared towards improving patient care and providing effective solutions to real-world medical challenges.

Collaborations

Throughout his career, Beddingfield has had the privilege of collaborating with talented colleagues, including Gurpreet Ahluwalia and Sydney G. Edwards. These partnerships have fostered a creative environment that encourages the exchange of ideas and propels the development of new therapeutic solutions.

Conclusion

Frederick C. Beddingfield's commitment to innovation in healthcare exemplifies the vital role inventors play in transforming patient care. With his patents focusing on the treatment of hypotrichosis due to chemotherapy, he continues to make a significant impact, ultimately improving the lives of countless individuals facing the challenges associated with cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…